DSGN·25056L103·US·equity·Healthcare - Biotechnology-Activist
DSGN (DESIGN THERAPEUTICS INC) is held by 78 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($31.6M), Point72 Asset Management, L.P. ($29M), BAKER BROS. ADVISORS LP ($27.5M). Net institutional sentiment: Bullish.
See how DSGN's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer